Not Yet RecruitingPhase 3ACTRN12606000100594

Baclofen for Alcohol Dependence

The safety and efficacy of baclofen for alcohol dependence: a double-blind randomised placebo-controlled trial

Sponsor

Sydney South West Area Health Service

Enrollment

42 participants

Start Date

May 1, 2006

Study Type

Interventional

Conditions

Alcohol Dependence

Summary

Ethics application submitted and responses to comments are being drafted presently.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying: Baclofen for Alcohol Dependence. It may be open to adults aged 18 to 60. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

12-week intervention comparing oral baclofen 10mg t.i.d versus oral baclofen 20mg t.i.d. for the treatment of alcohol dependence, and incorporating a manualised behavioural therapy for all participant